Presentation AHA 2017 Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial Presenter: Steven Weisbord November 13, 2017 REGISTER for free or LOG IN to view this content Coronary Imaging & Physiology Angiography/QCA Presentation AHA 2017 Up Next Presentation AHA 2017 Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes Presenter: Louise Bowman November 14, 2017 More slides + Presentation AHA 2017 Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial Presenter: Andre Lamy November 15, 2017 Presentation AHA 2017 One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study Presenter: Zuzana Motovska November 11, 2017 We Recommend
Presentation AHA 2017 Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes Presenter: Louise Bowman November 14, 2017
Presentation AHA 2017 Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial Presenter: Andre Lamy November 15, 2017
Presentation AHA 2017 One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study Presenter: Zuzana Motovska November 11, 2017